Treatment of hyperparathyroidism (HPT) and MBD is primarily based on the assessments of laboratory values of phosphate, calcium, PTH level, alkaline phosphatase, and vitamin D. The primary therapeutic approach is drug-based and aims primarily to identify and treat long-term trends. The gene discussed is PTH; the disease is Marchiafava-Bignami disease.